Karen A. Donato
Profile
Karen A.
Donato held several positions in different companies, including Principal at EIDP, Inc., Product Planner-Biomedical Materials at HNA Holdings, Inc., Vice President-Sales & Marketing at MaxCyte, Inc., Vice President-Marketing & Business Development at Bridge Pharmaceuticals, Inc., Vice President-Business Development at Bridge Global Pharmaceutical Services, Inc., Senior Research & Development Engineer at Ethicon, Inc., and Vice President-Sales & Marketing at Celsis in Vitro Technologies.
She obtained an undergraduate degree from the University of Pennsylvania and graduate and doctorate degrees from The Ohio University.
Former positions of Karen A. Donato
| Companies | Position | End |
|---|---|---|
Bridge Global Pharmaceutical Services, Inc.
 Bridge Global Pharmaceutical Services, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Global Pharmaceutical Services, Inc. provides toxicology, immunology, molecular biology and regulatory consulting and services. It also offers preclinical and early stage clinical trial drug development services to pharmaceutical and biotechnology industries. The company was founded in Stephen J. Trevisan and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2005-12-31 |
Bridge Pharmaceuticals, Inc.
 Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs. | Sales & Marketing | - |
| E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | - |
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Corporate Officer/Principal | - |
HNA Holdings, Inc.
 HNA Holdings, Inc. Chemicals: SpecialtyProcess Industries Part of Celanese Corp., HNA Holdings, Inc. is a manufacturer of inorganic dye and pigment. The company is based in Summit, NJ. | Corporate Officer/Principal | - |
Training of Karen A. Donato
| University of Pennsylvania | Undergraduate Degree |
| The Ohio University | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| MAXCYTE, INC. | Health Technology |
| Private companies | 6 |
|---|---|
| Celsis in Vitro Technologies | Health Technology |
HNA Holdings, Inc.
HNA Holdings, Inc. Chemicals: SpecialtyProcess Industries Part of Celanese Corp., HNA Holdings, Inc. is a manufacturer of inorganic dye and pigment. The company is based in Summit, NJ. | Process Industries |
Ethicon, Inc.
Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Health Technology |
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Bridge Global Pharmaceutical Services, Inc.
Bridge Global Pharmaceutical Services, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Global Pharmaceutical Services, Inc. provides toxicology, immunology, molecular biology and regulatory consulting and services. It also offers preclinical and early stage clinical trial drug development services to pharmaceutical and biotechnology industries. The company was founded in Stephen J. Trevisan and is headquartered in Gaithersburg, MD. | Commercial Services |
Bridge Pharmaceuticals, Inc.
Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs. | Commercial Services |
- Stock Market
- Insiders
- Karen A. Donato
